Biotech Damian Garde These pricey cholesterol drugs aren’t selling. And that has the biotech industry sweating
Pharmalot Ed Silverman Pharmalot, Pharmalittle: Pharma backs patients, docs who oppose Medicare Part B overhaul
Pharmalot Ed Silverman Pharmalot, Pharmalittle: Are too many companies chasing the same kind of cancer drug?